208 related articles for article (PubMed ID: 12843153)
1. Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter.
Nieuwlaat WA; Huysmans DA; van den Bosch HC; Sweep CG; Ross HA; Corstens FH; Hermus AR
J Clin Endocrinol Metab; 2003 Jul; 88(7):3121-9. PubMed ID: 12843153
[TBL] [Abstract][Full Text] [Related]
2. Radioiodine 131I treatment for large nodular goiter: recombinant human thyrotropin allows the reduction of radioiodine 131I activity to be administered in patients with low uptake.
Ceccarelli C; Antonangeli L; Brozzi F; Bianchi F; Tonacchera M; Santini P; Mazzeo S; Bencivelli W; Pinchera A; Vitti P
Thyroid; 2011 Jul; 21(7):759-64. PubMed ID: 21568727
[TBL] [Abstract][Full Text] [Related]
3. Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid-stimulating hormone.
Nieuwlaat WA; Hermus AR; Ross HA; Buijs WC; Edelbroek MA; Bus JW; Corstens FH; Huysmans DA
J Nucl Med; 2004 Apr; 45(4):626-33. PubMed ID: 15073259
[TBL] [Abstract][Full Text] [Related]
4. Administration of a single low dose of recombinant human thyrotropin significantly enhances thyroid radioiodide uptake in nontoxic nodular goiter.
Huysmans DA; Nieuwlaat WA; Erdtsieck RJ; Schellekens AP; Bus JW; Bravenboer B; Hermus AR
J Clin Endocrinol Metab; 2000 Oct; 85(10):3592-6. PubMed ID: 11061507
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment with recombinant human TSH changes the regional distribution of radioiodine on thyroid scintigrams of nodular goiters.
Nieuwlaat WA; Hermus AR; Sivro-Prndelj F; Corstens FH; Huysmans DA
J Clin Endocrinol Metab; 2001 Nov; 86(11):5330-6. PubMed ID: 11701700
[TBL] [Abstract][Full Text] [Related]
6. Single, very low dose (0.03 mg) of recombinant human thyrotropin (rhTSH) effectively increases radioiodine uptake in the I-131 treatment of large nontoxic multinodular goiter.
Mojsak MN; Abdelrazek S; Szumowski P; Rogowski F; Sykała M; Kostecki J; Kociura-Sawicka A; Jurgilewicz D; Myśliwiec J
Nucl Med Rev Cent East Eur; 2016; 19(1):3-11. PubMed ID: 26841373
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of administering 0.2 mg of recombinant human TSH for two consecutive days as an adjuvant to therapy with low radioiodine doses in elderly out-patients with large nontoxic multinodular goiter.
Giusti M; Cappi C; Santaniello B; Ceresola E; Augeri C; Lagasio C; Minuto F
Minerva Endocrinol; 2006 Sep; 31(3):191-209. PubMed ID: 17213787
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human thyrotropin before (131)I therapy in patients with nodular goitre: a meta-analysis of randomized controlled trials.
Lee YY; Tam KW; Lin YM; Leu WJ; Chang JC; Hsiao CL; Hsu MT; Hsieh AT
Clin Endocrinol (Oxf); 2015 Nov; 83(5):702-10. PubMed ID: 25370124
[TBL] [Abstract][Full Text] [Related]
9. Administration of a single dose of recombinant human thyrotrophin enhances the efficacy of radioiodine treatment of large compressive multinodular goitres.
Silva MN; Rubió IG; Romão R; Gebrin EM; Buchpiguel C; Tomimori E; Camargo R; Cardia MS; Medeiros-Neto G
Clin Endocrinol (Oxf); 2004 Mar; 60(3):300-8. PubMed ID: 15008994
[TBL] [Abstract][Full Text] [Related]
10. Optimizing 131I uptake after rhTSH stimulation in patients with nontoxic multinodular goiter: evidence from a prospective, randomized, double-blind study.
Fast S; Nielsen VE; Grupe P; Bonnema SJ; Hegedüs L
J Nucl Med; 2009 May; 50(5):732-7. PubMed ID: 19403877
[TBL] [Abstract][Full Text] [Related]
11. Transient goiter enlargement after administration of 0.3 mg of recombinant human thyrotropin in patients with benign nontoxic nodular goiter: a randomized, double-blind, crossover trial.
Nielsen VE; Bonnema SJ; Hegedüs L
J Clin Endocrinol Metab; 2006 Apr; 91(4):1317-22. PubMed ID: 16434453
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human thyrotropin stimulation prior to
Azorín Belda MJ; Martínez Caballero A; Figueroa Ardila GC; Martínez Ramírez M; Gómez Jaramillo CA; Dolado Ardit JI; Verdú Rico J
Rev Esp Med Nucl Imagen Mol; 2017; 36(1):7-12. PubMed ID: 27422154
[TBL] [Abstract][Full Text] [Related]
13. Improvement of goiter volume reduction after 0.3 mg recombinant human thyrotropin-stimulated radioiodine therapy in patients with a very large goiter: a double-blinded, randomized trial.
Bonnema SJ; Nielsen VE; Boel-Jørgensen H; Grupe P; Andersen PB; Bastholt L; Hegedüs L
J Clin Endocrinol Metab; 2007 Sep; 92(9):3424-8. PubMed ID: 17566091
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human TSH increases the efficacy of a fixed activity of radioiodine for treatment of multinodular goitre.
Cubas ER; Paz-Filho GJ; Olandoski M; Goedert CA; Woellner LC; Carvalho GA; Graf H
Int J Clin Pract; 2009 Apr; 63(4):583-90. PubMed ID: 18803554
[TBL] [Abstract][Full Text] [Related]
15. Effect of recombinant human TSH on the uptake of radioactive iodine ((123)I) by the thyroid gland in healthy beagles.
Campos M; Peremans K; Duchateau L; Dobbeleir A; Vandermeulen E; van Hoek I; Paes G; Daminet S
Domest Anim Endocrinol; 2010 Nov; 39(4):215-21. PubMed ID: 20688462
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human thyrotropin markedly changes the 131I kinetics during 131I therapy of patients with nodular goiter: an evaluation by a randomized double-blinded trial.
Nielsen VE; Bonnema SJ; Boel-Jørgensen H; Veje A; Hegedüs L
J Clin Endocrinol Metab; 2005 Jan; 90(1):79-83. PubMed ID: 15494456
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human thyrotropin-stimulated radioiodine therapy of nodular goiter allows major reduction of the radiation burden with retained efficacy.
Fast S; Hegedüs L; Grupe P; Nielsen VE; Bluhme C; Bastholt L; Bonnema SJ
J Clin Endocrinol Metab; 2010 Aug; 95(8):3719-25. PubMed ID: 20519346
[TBL] [Abstract][Full Text] [Related]
18. Human recombinant TSH preceding a therapeutic dose of radioiodine for multinodular goiters has no significant effect in the surge of TSH-receptor and TPO antibodies.
Rubio IG; Perone BH; Silva MN; Knobel M; Medeiros-Neto G
Thyroid; 2005 Feb; 15(2):134-9. PubMed ID: 15753672
[TBL] [Abstract][Full Text] [Related]
19. Radioiodine plus recombinant human thyrotropin do not cause acute airway compression and are effective in reducing multinodular goiter.
Albino CC; Graf H; Paz-Filho G; Diehl LA; Olandoski M; Sabbag A; Buchpiguel C
Braz J Med Biol Res; 2010 Mar; 43(3):303-9. PubMed ID: 20401438
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of various doses of recombinant human thyrotropin in patients with multinodular goiters.
Braverman L; Kloos RT; Law B; Kipnes M; Dionne M; Magner J
Endocr Pract; 2008 Oct; 14(7):832-9. PubMed ID: 18996810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
